TriCelX Takes On Alzheimer’s — Its Third Brain Disease, and the Largest
FRISCO, TX, UNITED STATES, October 21, 2026 /EINPresswire.com/ -- TriCelX, Inc. today announced that it filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration to test XytriX™, its investigational …